A publicly listed company for more than 3 decades, adding shareholder revenue value of 20% YoY and having a market cap of more than 10,000 CR, Glenmark is a pharmaceutical behemoth. The annual report for any company is a foundational corporate tenet for investors around the world, more importantly for a publicly listed corporation and most importantly for a corporation the scale of Glenmark.
Pineapple has been creating annual reports for Glenmark year after year to bring out the context behind the content, the information behind the data. Conveying a unified global message, effectively articulating a plethora of numbers and maintaining a corporate vision through the reports with evolving global dynamics, is the challenge faced head on every year.
The pandemic tested the strength and perseverance of everyone alike globally. More so for the pharmaceutical companies as they had the responsibility of supporting the medical fraternity while ensuring that the teams remain safe along with addressing their responsibility towards the global community and society at large.
Hence, it was imperative to address these aspects of corporate responsibility toward multiple consumer groups, both individual and institutional, through a document that is one of the key tenets of a corporation.
Though it was a financial report, the 2020 annual report was supposed to not only reflect the past performance and future projections, but also the sensitivity with which the company was approaching the vision to steer ahead in globally challenging times.
The report highlighted the various initiatives taken and the preparedness of the company especially during the pandemic times.
Objective developments such as the branching out of its API business vertical into a separate company were given prominence in the report.
Every financial report has objectives beyond just communicating the numbers. The report for 2018-19 needed to effectively convey the company’s dedicated efforts towards its transformation from a generic API drug manufacturer to a world class pharmaceutical spreading its wings wide as a research driven company. Pineapple was mandated to deliver a visual impact to the growth story that the financial statements were narrating.
